Business Description
Acotec Scientific Holdings Ltd
ISIN : KYG0096M1096
Total Employee Number:
653Compare
Compare
Traded in other countries / regions
06669.Hong Kong7W3.Germany IPO Date
2021-08-24Description
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions. The firm generates the majority of its revenue from sales to Domestic distributors.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.17 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -4.82 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 4.02 | |||||
Beneish M-Score | -1.86 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 17 | |||||
3-Year EBITDA Growth Rate | 25.9 | |||||
3-Year EPS without NRI Growth Rate | 13.9 | |||||
3-Year Book Growth Rate | 4.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.52 | |||||
9-Day RSI | 37.34 | |||||
14-Day RSI | 37.89 | |||||
3-1 Month Momentum % | -12.05 | |||||
6-1 Month Momentum % | -31.36 | |||||
12-1 Month Momentum % | -32.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.4 | |||||
Quick Ratio | 4.73 | |||||
Cash Ratio | 3.31 | |||||
Days Inventory | 289.43 | |||||
Days Sales Outstanding | 137.27 | |||||
Days Payable | 115.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -0.8 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 71.8 | |||||
Operating Margin % | -6.15 | |||||
Net Margin % | -8.43 | |||||
EBITDA Margin % | -6.56 | |||||
FCF Margin % | 10.62 | |||||
OCF Margin % | 23.22 | |||||
ROE % | -3.71 | |||||
ROA % | -2.92 | |||||
ROIC % | -4.67 | |||||
3-Year ROIIC % | 21.53 | |||||
ROC (Joel Greenblatt) % | -7.53 | |||||
ROCE % | -2.61 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 10.11 | |||||
Price-to-Owner-Earnings | 14.74 | |||||
PS Ratio | 2.7 | |||||
PB Ratio | 1.24 | |||||
Price-to-Tangible-Book | 1.25 | |||||
Price-to-Free-Cash-Flow | 25.46 | |||||
Price-to-Operating-Cash-Flow | 11.66 | |||||
EV-to-EBIT | -29.75 | |||||
EV-to-EBITDA | -29.75 | |||||
EV-to-Revenue | 1.95 | |||||
EV-to-FCF | 18.39 | |||||
Price-to-GF-Value | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 1.86 | |||||
| Price-to-Net-Cash | 4.11 | |||||
Earnings Yield (Greenblatt) % | -3.36 | |||||
FCF Yield % | 3.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acotec Scientific Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 707.695 | ||
| EPS (TTM) (HK$) | -0.202 | ||
| Beta | 0.6889 | ||
| 3-Year Sharpe Ratio | -0.25 | ||
| 3-Year Sortino Ratio | -0.36 | ||
| Volatility % | 36.3 | ||
| 14-Day RSI | 37.89 | ||
| 14-Day ATR (HK$) | 0.387262 | ||
| 20-Day SMA (HK$) | 6.78725 | ||
| 12-1 Month Momentum % | -32.76 | ||
| 52-Week Range (HK$) | 5.99 - 15.47 | ||
| Shares Outstanding (Mil) | 313.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acotec Scientific Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acotec Scientific Holdings Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acotec Scientific Holdings Ltd Frequently Asked Questions
What is Acotec Scientific Holdings Ltd(HKSE:06669)'s stock price today?
The current price of HKSE:06669 is HK$6.37. The 52 week high of HKSE:06669 is HK$15.47 and 52 week low is HK$5.99.
When is next earnings date of Acotec Scientific Holdings Ltd(HKSE:06669)?
The next earnings date of Acotec Scientific Holdings Ltd(HKSE:06669) is .
Does Acotec Scientific Holdings Ltd(HKSE:06669) pay dividends? If so, how much?
Acotec Scientific Holdings Ltd(HKSE:06669) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Acotec Scientific Holdings Ltd
No articles.